Oculogica has received FDA clearance for its portable eye-tracking device, SNAP, designed to objectively diagnose concussions on the sidelines. The device captures involuntary eye movements, which are disrupted by concussions, and integrates this data with symptom input to provide a SNAP Score within 90 seconds. This new method aims to overcome the limitations of subjective assessments that athletes can potentially manipulate. AI
RANK_REASON The item details the FDA clearance and validation of a new medical device for concussion diagnosis, which falls under research and product development. [lever_c_demoted from research: ic=1 ai=0.1]
- Children's Hospital of Philadelphia
- Dr. Christina Master
- Dr. Rosina Samadani
- Keller Army Hospital
- Kenneth L. Cameron
- New York
- Oculogica Portable EyeBOX Study
- SNAP
- United States Food and Drug Administration
- United States Military Academy
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
